Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System
Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder. De Novo DEN170078, from Brainways , Ltd. (Har Hotzvim, IL). Product code QCI, class 2.
As of Nov 22, 2026, DEN170078 is an FDA De Novo held by Brainways , Ltd., granted on Aug 17, 2018 after 322 days, with no recalls tied to it in FDA's recall database.
- Review time: 322 days
- Recalls: 0
- Cited as a predicate by: 4 devices
The Brainsway Deep Transcranial Magnetic Stimulation System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder. FDA concludes that this device should be classified into Class II.
- Design
- Randomized, double-blind, multi-site, sham-controlled study (1:1 allocation)
- Enrolled
- 100
- Where
- 11 sites, US, Israel, Canada
- Primary endpoint
- Change from baseline in YBOCS score to 6 weeks, DTMS vs. sham
- Result
- Met on mITT: DTMS -6.0 vs. Sham -3.3 points, difference 2.8 (p=0.0127); ITT difference 1.9 not significant (p=0.0988)
- BrainsWay Deep TMS SystemK220819 · Brainsway , Ltd. · Aug 26, 2022
- Brainsway Deep TMS SystemK200957 · Brainsway , Ltd. · Aug 21, 2020
- MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemK193006 · Tonica Elektronik A/S · Aug 9, 2020
- Brainsway Deep TMS SystemK183303 · Brainsway , Ltd. · Mar 8, 2019
- Ultimate rTMS for OCD (M-series)K243459 · Brain Ultimate, Inc. · Apr 17, 2025
- BTL-99-OCK230657 · BTL Industries, Inc. · Feb 1, 2024
- CloudTMS Edge for OCDK233742 · Teleemg, LLC · Dec 22, 2023
- OCD MT Cap (85-00397-000)K231350 · Neuronetics · Jun 8, 2023
- CloudTMS for OCDK221129 · Teleemg, LLC · Mar 10, 2023
- NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy…K212289 · Neuronetics, Inc. · May 6, 2022
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Sep 29, 2017
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5802
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files